Literature DB >> 22727840

Comparison of outcomes with coils versus vascular plug embolization of the internal iliac artery for endovascular aortoiliac aneurysm repair.

Evan J Ryer1, Robert P Garvin, Travis P Webb, David P Franklin, James R Elmore.   

Abstract

OBJECTIVE: To compare the safety and efficacy of coil embolization (COIL) to Amplatzer vascular plug embolization (PLUG) to achieve internal iliac artery (IIA) occlusion prior to endovascular aortiliac aneurysm repair (EVAR).
METHODS: Data from consecutive patients who underwent IIA embolization prior to EVAR over a 6-year period (2004-2010) were retrospectively reviewed. Patient demographics, treatment modalities, and outcomes were compared.
RESULTS: From January 1, 2004 to December 31, 2010, a total of 53 patients underwent percutaneous embolization of 57 IIAs prior to EVAR. Twenty-nine IIAs underwent COIL and 28 IIAs underwent PLUG embolization. Patient demographics and risk factors were similar between the two groups. Patients underwent repair for aneurysmal dilation of the infrarenal aorta in conjunction with the common or internal iliac arteries (n = 35, 62%) or isolated iliac artery aneurysms (n = 19, 38%). A significantly greater number of embolization devices were used in the COIL group (5.8 ± 3.8 vs 1.1 ± 0.4; P < .0001). Patients undergoing PLUG embolization demonstrated significantly shorter procedure times (118.4 ± 64.7 minutes vs 72.6 ± 22.4 minutes; P = .008) and fluoroscopy times (32.6 ± 14.6 vs 14.4 ± 8.6 minutes; P = .002). However, radiation dose between the groups did not differ (COIL: 470,192.7 ± 190,606.6 vs PLUG: 300,972.2 ± 191,815.7 mGycm(2); P = .10). Overall periprocedural morbidity did not differ between the groups (COIL: 11% vs PLUG: 6%; P = 1.0), and there were no perioperative mortalities or severe complications. Nontarget embolization occurred in two COIL and no PLUG cases (COIL: 6.9% vs PLUG: 0%; P = .49). Patient-reported buttock claudication at 1 month was 17.2% for COIL and 39.3% for PLUG patients (P = .08). At last follow-up, persistent buttock claudication was reported in 13.8% of COIL and in 14.3% of PLUG embolizations (P = 1.0). There was no significant difference in charges for the embolization material, operating room, or overall hospital charges (COIL: 44,720 ± 19,153 vs 37,367 ± 10,915; P = .22). Lastly, zero endoleaks in the COIL group and three in the PLUG group (P = .40) were detected on the most recent follow-up computed tomography imaging. No endoleak was related to the site of IIA embolization.
CONCLUSIONS: COIL and PLUG embolization both provide effective IIA embolization with low complication rates when used for EVAR. Buttock claudication did occur in approximately one-third of patients but resolved in half of those affected. PLUG embolization took significantly less time to perform and required decreased fluoroscopy times. Based on outcomes and cost-analysis, COIL and PLUG embolization are equivalent methods to achieve IIA occlusion during EVAR.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727840     DOI: 10.1016/j.jvs.2012.05.001

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

1.  Outcomes of Endovascular Repair of Aortoiliac Aneurysms and Analyses of Anatomic Suitability for Internal Iliac Artery Preserving Devices in Japanese Patients.

Authors:  Nathan K Itoga; Naoki Fujimura; Keita Hayashi; Hideaki Obara; Hideyuki Shimizu; Jason T Lee
Journal:  Circ J       Date:  2017-02-02       Impact factor: 2.993

2.  Direct aneurysm sac catheterization and embolization of an enlarging internal iliac aneurysm using cone-beam CT.

Authors:  Monish Merchant; Rohan Shah; Scott Resnick
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

3.  High-flow carotid cavernous fistula and the use of a microvascular plug system: initial experience.

Authors:  Yamin Shwe; Srinivasan Paramasivam; Santiago Ortega-Gutierrez; David Altschul; Alejandro Berenstein; Johanna T Fifi
Journal:  Interv Neurol       Date:  2015-03

4.  Effectiveness of exclusion of a persistent sciatic artery aneurysm with an Amplatzer™ plug.

Authors:  Allen Lee; Stephen E Hohmann; William P Shutze
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

5.  Proximal occlusion of unaffected internal iliac artery versus distal occlusion of aneurysmatic internal iliac artery prior to EVAR: a comparative evaluation of efficacy and clinical outcome.

Authors:  Alexander Dierks; Alexander Sauer; Franziska Wolfschmidt; Nicole Hassold; Richard Kellersmann; Thorsten A Bley; Ralph Kickuth
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

6.  Successful Treatment of Iatrogenic External Iliac Artery Perforation With Covered Stent: Case Report and Review of the Literature.

Authors:  Muhammad Umer Awan; Bassam Omar; Ghazanfar Qureshi; Ghulam Mustafa Awan
Journal:  Cardiol Res       Date:  2017-10-27

7.  Conservative management of a ruptured mycotic aneurysm.

Authors:  Freya Lodge; Nerys Conway; Nick Waterfield
Journal:  BMJ Case Rep       Date:  2013-05-15

8.  Compressed Amplatzer Vascular Plug II Embolization of the Left Subclavian Artery for Thoracic Endovascular Aortic Repair is Efficient and Safety Method Comparable to Conventional Coil Embolization.

Authors:  Kensuke Matsumoto; Yasufumi Ohuchi; Shinsaku Yata; Akira Adachi; Masayuki Endo; Shohei Takasugi; Shinya Fujii; Masayuki Hashimoto; Toshio Kaminou; Toshihide Ogawa; Yoshikazu Fujiwara; Munehiro Saiki; Motonobu Nishimura
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

Review 9.  [Isolated iliac artery aneurysms : Interventional treatment].

Authors:  T Pfammatter; A Kobe; M L Lachat
Journal:  Radiologe       Date:  2018-09       Impact factor: 0.635

Review 10.  Update on abdominal aortic aneurysm research: from clinical to genetic studies.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Irene Hinterseher; Diane T Smelser; Gerard Tromp
Journal:  Scientifica (Cairo)       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.